Zaki, R.M.; Alfadhel, M.M.; Alshahrani, S.M.; Alsaqr, A.; Al-Kharashi, L.A.; Anwer, M.K.
Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines. Pharmaceuticals 2022, 15, 348.
https://doi.org/10.3390/ph15030348
AMA Style
Zaki RM, Alfadhel MM, Alshahrani SM, Alsaqr A, Al-Kharashi LA, Anwer MK.
Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines. Pharmaceuticals. 2022; 15(3):348.
https://doi.org/10.3390/ph15030348
Chicago/Turabian Style
Zaki, Randa Mohammed, Munerah M. Alfadhel, Saad M. Alshahrani, Ahmed Alsaqr, Layla A. Al-Kharashi, and Md Khalid Anwer.
2022. "Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines" Pharmaceuticals 15, no. 3: 348.
https://doi.org/10.3390/ph15030348
APA Style
Zaki, R. M., Alfadhel, M. M., Alshahrani, S. M., Alsaqr, A., Al-Kharashi, L. A., & Anwer, M. K.
(2022). Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines. Pharmaceuticals, 15(3), 348.
https://doi.org/10.3390/ph15030348
